News Briefs

Moderna, Inc. and Pfizer Inc./ BioNTech said on Jan. 25 that their vaccines are effective against new variants of the virus discovered in South Africa and the United Kingdom, the New York Times reported. However, the drugmakers said their vaccines are slightly less protective against the South African variant, and therefore Moderna said it is developing a booster shot against that variant as a precautionary measure. Meanwhile, on Jan. 20, President Joe Biden said the government is aiming to vaccinate 300 million Americans by early fall. Read more at https://nyti.ms/36llVuq.

The Government Accountability Office (GAO) found that the Dept. of Veterans Affairs (VA) pays far less than Medicare Part D for most prescription drugs. According to the report, the VA “paid, on average, 54 percent less per unit for a sample of 399 brand-name and generic prescription drugs in 2017 as did Medicare Part D, even after accounting for applicable rebates and price concessions in the Part D program.” The VA’s average price paid for generics is 68% lower than Medicare prices and 49% lower for brand name drugs. This may be due to key structural differences in the programs, suggested the report. Read more at https://bit.ly/2M9ltJ0.

© 2022 MMIT
AIS Health Staff

AIS Health Staff

Related Posts

pills
September 22

Report Shows Limited Access to Opioid Use Disorder Treatments for Medicare Beneficiaries

READ MORE
cms-website
September 22

Drug Price Negotiation Will Require New CMS Regulations, Staffing

READ MORE
fda-sign
September 22

Accelerated Approval Prices Are Unrelated to Clinical Value, Study Says

READ MORE

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today